Kashnol® (Kashnol®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspsyrup
Composition:

5 ml of syrup (two teaspoons) contain active substances:

Salbutamol sulfate - 1 mg, bromhexine hydrochloride - 2 mg, guaifenesin-50 mg, menthol -0.5 mg

Excipients:

Sucrose, citric acid monohydrate, sodium edetate, sodium benzoate, potassium sorbate, propylene glycol, glycerin, sorbitol solution 70%, crimson 4 R, aroma of raspberry

Description:

The liquid is red with the smell of raspberry and sweet taste.

Pharmacotherapeutic group:Combined drug. Bronchillitis, mucolytic, expectorant
Pharmacodynamics:

Combination drug consisting of ingredients used for the symptomatic treatment of cough for various lung diseases, which has bronchodilator, mucolytic and expectorant action.

Salbutamol - has a bronchodilator effect by selective action on beta-2-adrenergic bronchial receptors.

Bromhexine - dilutes sputum, increases its volume. Mucolytic action is due to the ability, depolymerize and dilute mucoproteins and mucopolysaccharide fibers.

Guafenizine - has an expectorant effect. Reduces adhesiveness, surface tension of sputum, which improves its departure.

Menthol - has a weak antiseptic properties, has a calming effect and reduces irritation of the mucous membrane of the respiratory tract.

Indications:

Acute and chronic bronchopulmonary diseases, accompanied by difficulty in sputum discharge (bronchial asthma, tracheobronchitis, obstructive bronchitis, pneumonia, pulmonary emphysema, pneumoconiosis, etc.)

Contraindications:

Hypersensitivity to components of the drug; pregnancy, lactation, tachycardia, myocarditis, heart defects, decompensated diabetes mellitus, thyrotoxicosis, glaucoma, hepatic or renal insufficiency, galactose malabsorption (because the preparation contains sucrose and sorbitol).

Carefully:The drug Kashnol should be used carefully in patients with diabetes mellitus, hypertension, peptic ulcer of the stomach and duodenal ulcer in remission.
Pregnancy and lactation:If you need to treat Kashnol during lactation, breastfeeding should be discontinued.
Dosing and Administration:

The drug Kashnol is prescribed for adults and children over 12 years of 10 ml (2 teaspoons) 3 times a day, children under 6 years - 5 ml (1 teaspoon) 3 times a day, children from 6 to 12 years - 5-10 ml (1-2 teaspoons) 3 times a day.

Side effects:

Sometimes there is a headache, dizziness, increased nervous excitability, sleep disturbance, drowsiness, tremor, convulsions, nausea, vomiting, diarrhea, peptic ulcer and palpitations, palpitations, possibly urine pink, allergic reactions (rash, urticaria ), lowering of arterial pressure, collapse.

Overdose:

No cases of overdose have been reported. Possible enhancement of the above side effects. Treatment is symptomatic.

Interaction:

Other beta-2-adrenomimetic agents and theophylline increase the effect of salbutamol and increase the likelihood of side effects.

Cough is not prescribed concomitantly with drugs containing codeine and other antitussive agents, as this makes it difficult to move away diluted sputum.

Included in the drug Kashnol bromohexine, promotes the penetration of antibiotics (erythromycin, cephalexin, oxytetracycline) into the lung tissue.

It is not recommended to use Kashnol at the same time as non-selective beta-adrenoreceptor blockers, such as propranolol.

Included in the drug Kashnol salbutamol It is not recommended for patients who receive MAO inhibitors.

Diuretics and preparations of glucocorticosteroids increase the hypokalemic effect of salbutamol.

Alkaline drink is not recommended at the same time as Kashnol.

Form release / dosage:

Syrup.

Packaging:

100 ml or 200 ml in a bottle of dark glass, sealed with a screwed aluminum cover with the control of the first opening and with a plastic measuring cup N 1; 1 bottle together with instructions for use in a cardboard box.

Storage conditions:

Store at a temperature of no higher than 25 ° C, protected from light and out of the reach of children.

Shelf life:

3 years.

Do not use after the expiration date.

Terms of leave from pharmacies:On prescription
Registration number:П N014296 / 01
Date of registration:12.02.2010 / 03.06.2015
Expiration Date:Unlimited
The owner of the registration certificate:Sedeit Halskar (P) LtdSedeit Halskar (P) Ltd India
Manufacturer: & nbsp
Representation: & nbspZAO NPC ELFA ZAO NPC ELFA Russia
Information update date: & nbsp26.12.2017
Illustrated instructions
    Instructions
    Up